Kingworld Medicines Group Limited (HKG:1110)
0.5300
-0.0100 (-1.89%)
Sep 8, 2025, 3:55 PM HKT
Kingworld Medicines Group Revenue
Kingworld Medicines Group had revenue of 404.85M CNY in the half year ending June 30, 2025, a decrease of -26.79%. This brings the company's revenue in the last twelve months to 939.84M, down -10.64% year-over-year. In the year 2024, Kingworld Medicines Group had annual revenue of 1.06B, down -1.63%.
Revenue (ttm)
939.84M CNY
Revenue Growth
-10.64%
P/S Ratio
0.30
Revenue / Employee
966.92K CNY
Employees
972
Market Cap
312.49M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.06B | -17.58M | -1.63% |
Dec 31, 2023 | 1.08B | 120.96M | 12.63% |
Dec 31, 2022 | 957.70M | 110.32M | 13.02% |
Dec 31, 2021 | 847.39M | 102.00M | 13.68% |
Dec 31, 2020 | 745.38M | -232.55M | -23.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |